THURESA CASH: Open Payments
NPI 1659511103 · WHITLEY CITY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 36 payments from 13 companies in 2025. Trend: 2023 $573 · 2024 $631 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $216 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: VRAYLAR, QULIPTA, Auvelity, CAPLYTA, FANAPT, REXULTI, UBRELVY, ARISTADA.
Industry payments across KY — which companies pay providers there.
